HALOZYME THERAPEUTICS INC 5
5 · HALOZYME THERAPEUTICS INC · Filed Feb 8, 2005
Insider Transaction Report
Form 5
Engler Robert
Director
Transactions
- Award
Options to Purchase Common Stock
2004-10-13$2.05/sh+75,000$153,750→ 75,000 totalExercise: $2.05From: 2004-10-13Exp: 2014-10-13→ Common Stock (75,000 underlying) - Award
Options to Purchase Common Stock
2004-05-21$4.10/sh+150,000$615,000→ 150,000 totalExercise: $4.10From: 2004-06-21Exp: 2014-05-21→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Options vest monthly over a period of 36 months, contingent upon continued participation as a member of the Board of Directors of Issuer.
- [F2]Options vest over a period of 6 months, with 50% vesting on date of grant, and remainder vesting monthly, contingent upon continued participation as a member of the Board of Directors of Issuer.